Holen Sie sich die Stockscreener-App
38.84
7.26%
2.63
Finanzdaten der Monopar Therapeutics Inc-Aktie (MNPR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | 0.0735 |
Operating Expenses
|
0.39%
3.2343
|
3.2218 | 11.07 | 1.5749 | 1.7888 |
| Operating Income/Loss |
0.39%
-3.2343
|
-3.2218 | -11.07 | -1.5749 | -1.7888 |
| Income/Loss From Continuing Operations Before Tax |
6.53%
-2.4535
|
-2.625 | -10.92 | -1.3043 | -1.7153 |
| Income/Loss From Continuing Operations After Tax |
6.53%
-2.4535
|
-2.625 | -10.93 | -1.3043 | -1.7153 |
|
Net Income/Loss
|
6.53%
-2.4535
|
-2.625 | -10.93 | -1.3043 | -1.7153 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.15%
6.9981
|
6.9874 | 0.3709 | 3.5204 | 17.51 |
| Basic Earnings Per Share |
7.89%
-0.35
|
-0.38 | -2.75 | -0.37 | -0.10 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):